Articles tagged with Cell Surface Receptors
Researchers at MIT have developed a novel sensor that can detect immune molecule CXCL12, which plays a crucial role in several human diseases including cancer. The device uses receptor proteins found in cell membranes, making it a potential tool for early screening of hard-to-diagnose cancers.
Researchers found that BUB1 protein regulates EGFR signaling by reducing receptor internalization, which may lead to new therapeutic interventions for EGFR-driven cancers. The study also showed that BUB1 impacts receptor recycling and degradation, affecting signaling amplitude and duration.
Researchers from Rice University and Princeton University have developed a new technology that allows for the live monitoring of signaling protein networks in living cells. The 'live reporter' system uses unobtrusive proteins to tag specific proteins, which can activate fluorescent markers when they become phosphorylated.
A team from the University of Ottawa has developed a comprehensive screening platform and cellular interrogation tool to facilitate novel drug discovery targeting various human diseases. The 'Tango-Trio' platform can identify small molecule modulators for orphan GPCRs, which have significant untapped therapeutic potential.
Researchers have identified a unique immune checkpoint receptor, KIR3DL3, found primarily in the intestine and lungs, suggesting its potential as a target for immunotherapies. This discovery could lead to new treatments for diseases such as lung and bowel cancer and autoimmune conditions like IBD.
A recent study unveiled the doorway that SARS-CoV2 uses to slip inside cells undetected. Cholesterol clusters make up this door, allowing the virus to infect human cells. Regular exercise and mechanical force can disrupt these cholesterol aggregates, reducing the risk of infection.
UCF researcher Dr. Justine Tigno-Aranjuez has discovered a new receptor that recognizes house dust mite allergens, opening up potential for broad-spectrum therapy. The finding could lead to improved treatments for common allergies, including asthma.
Researchers found that coronaviruses, like SARS-CoV-2, bind to individual monomeric ACE2 receptors on host cells, rather than forming dimers or oligomers. This interaction is sufficient for infection and contributes to the virus's high infectiousness.
A UNIGE team has identified how the influenza A virus manages to penetrate cells to infect them by hijacking the iron transport mechanism. By blocking this receptor, researchers were able to significantly reduce its ability to invade cells, highlighting a potential strategy for treating influenza virus infections.
University of Pittsburgh researchers created a universal receptor system allowing T cells to recognize any cell surface target. This enables highly customizable CAR T cell and other immunotherapies for treating cancer and diseases, with potential applications in solid tumors.
Researchers found that a specific neuropeptide affects two separate groups of neurons, promoting aggressive behavior in fruit flies. This discovery provides new insights into the complex mechanisms of neuronal communication using neuropeptides.
Researchers have observed beta-arrestin molecules directly controlling receptor-mediated signals in living cells using advanced microscopy. The study reveals a new mechanism of how these proteins interact with receptors on the plasma membrane, enabling efficient control of signal flow and desensitization.
Researchers at IOCB Prague have determined the first cryo-EM structures of a surface receptor of Trypanosoma brucei gambiense in complex with human complement factor C3. This discovery sheds light on how the parasite avoids clearance from the human bloodstream and survives within the immune system.
Researchers at UNIGE discovered that natural opioids cannot enter cells, whereas therapeutic opioids can, leading to differences in physiological responses. The study's findings could help develop safer medications with improved efficacy and reduced side effects.
Researchers analyzed octopus and squid sensory receptors to discover new families of chemotactile receptors that drive distinct behaviors in the environment. These findings provide insights into the molecular basis of novelty across levels of biological organization.
Scientists have engineered a unique strain of probiotic bacteria to over-express a metal transporter that binds and concentrates copper, facilitating the delivery of radionuclide therapy to cancer cells. This approach targets tumors without relying on specific receptors, making it potentially effective against treatment-resistant cancers.
Researchers at Arizona State University describe an innovative therapy using transient expression in tobacco plants to produce a monoclonal antibody against SARS-CoV-2. This class 4 mAb provides key advantages over existing treatments, including mutation resistance and universal protection against emerging variants.
Researchers have found that the naturally occurring amino acid ALA can reduce the expression of ACE2 on cell membranes, potentially lowering SARS-CoV-2's infectious capabilities. The study also reveals an underlying mechanism involving the production of heme, which is boosted by co-administering ALA with an iron source.
Researchers at UC Davis found that engaging serotonin 2A receptors inside neurons promotes growth of new connections, while the same receptors on cell surfaces do not. This discovery guides efforts to develop new treatments for depression and PTSD.
Researchers from ETH Zurich elucidated the structure and function of tryptophan C-mannosyltransferase (CMT), a glycosyltransferase enzyme involved in C-mannosylation. The study reveals the enzyme's novel mechanism, enabling precise understanding of protein sequences and sugar substrates.
Researchers identify an off-patent liver disease drug that can prevent SARS-CoV-2 entry into cells, potentially offering protection against future variants. The study used a unique combination of 'mini-organs', animal studies, and human subjects to demonstrate the drug's effectiveness.
USCF researchers have developed a new approach called CAR Pooling to compare different re-engineered T cells with varying molecular features. The screen revealed new and surprising receptors that make these therapeutic cells more powerful, promising a better treatment for blood cancers.
Researchers found two Korean native plants' saponins inhibit SARS-CoV-2 entry into cells by blocking membrane fusion. These compounds show promise in treating COVID-19, especially for asymptomatic cases.
A study reveals that interleukin 34 (IL-34) modulates the balance between two myeloid-derived suppressor cell populations, leading to immunosuppression and chemoresistance in triple-negative breast cancer. Neutralizing IL-34 with a drug reduces tumor growth and susceptibility to chemotherapy.
Scientists have elucidated the exact molecular structure of an IgM-type B cell receptor, revealing its asymmetrical complex with signaling subunits. The discovery provides insights into how the receptor interacts with other molecules and could lead to a better understanding of vaccine development and lymphoma formation.
A study led by University of Pennsylvania scientists reveals how tumor-derived factors stimulate trogocytosis, a process that can help cancer cells evade detection and grow unchecked. Blocking this process improved the effectiveness of CAR T cell therapy in mice.
Researchers at Johns Hopkins Medicine discover that nasal cell receptors activate few G protein molecules to produce a signal, contradicting the mainstream idea of high amplification. The study found that the probability of an odorant receptor activating just one G protein is 1 in 10,000, supporting weak signaling.
Researchers captured first image of antigen-bound T-cell receptor complex with bound antigen at atomic resolution. The study reveals no significant structural changes in the receptor after antigen binding, sparking further investigation into the signaling pathway activation mechanism.
Researchers developed a peptide that can be administered through nasal spray to reduce seizure activity and protect neurons in both Alzheimer's and epilepsy. The A1R-CT peptide inhibits neurabin, a protein that prevents the overactivation of neurons, allowing for increased action by adenosine receptors.
A new study provides critical insights into the pGC-A membrane receptor, a vital component of cardiovascular regulation. The research offers a clearer understanding of this complex receptor and its signaling mechanisms, paving the way for new anti-hypertensive drugs.
Scientists have developed a DNA nano-robot that can apply forces with unprecedented accuracy, enabling closer study of mechanical forces at microscopic levels. The robot is designed to target specific mechanoreceptors, allowing researchers to activate them and study key signaling pathways involved in biological processes.
Researchers create CDyB, a fluorescent probe that targets SLC35C2 transporter in B cells, allowing for live-cell distinction from T cells. The study enriches the molecular probe toolbox and opens possibilities for multi-dimensional cell analysis.
A new study suggests that current vaccine boosters intensify protections against serious infection caused by Omicron subvariants. The research found that booster doses bring neutralizing antibodies to appreciable levels against all Omicron subvariants, consistent with other evidence of expanded memory B cells and antibody production.
The study reveals how the EGF receptor changes its shape when binding to its target, triggering cell growth and proliferation. The findings could lead to the design of new cancer drugs that evade resistance, says MIT chemist Gabriela Schlau-Cohen.
Researchers created an atomic-level computational model of the COVID-19 spike protein, finding that human cell modifications increase its flexibility and mobility. The study suggests that these modifications can enhance virus infectivity and immune avoidance.
Researchers discovered that midgestation leptin surge in preeclampsia leads to endothelial dysfunction, blood vessel constriction, and restricted fetal growth. This finding highlights the crucial role of leptin in pregnancy and its potential consequences on maternal and infant cardiovascular health.
Researchers have discovered proteins that mediate intimate contacts between bacteria, enabling DNA transfer and resistance to antibiotics. Understanding this process can help develop new approaches to slow the spread of antimicrobial resistance.
Researchers at UT Health San Antonio found that rapamycin causes an increase in beta-amyloid protein plaques in mouse models, contradicting its potential benefits. However, a novel method to decrease plaques was discovered by deleting the Tsc1 gene from microglia, leading to increased Trem2 levels and decreased plaques.
Researchers designed artificial peptides that can bind to viral proteins, blocking entry into cells and causing viruses to clump together. These 'miniproteins' were found to be thermostable and safe for use in humans, with promising results in lab tests and animal models.
Researchers at Hokkaido University identified two deubiquitinating enzymes, UBP12 and UBP13, that stabilize the brassinosteroid receptor BRI1 in plant cells. This finding reveals a crucial role for these enzymes in regulating plant growth and development.
Researchers at UNIGE found that olfactory neurons change their identity based on expressed receptors and past experiences. The study reveals a wide range of identities among these neurons, which adapt rapidly to different levels of stimulation.
Finnish researchers created a comprehensive map of molecular interactions between 58 human receptor tyrosine kinases (RTKs), revealing key insights into their functions and roles in disease. The study's findings can aid understanding of diseases linked to abnormal RTK activity, particularly cancer.
A study suggests that the powerhouse-pruning protein Drp1 plays a crucial role in generating energy for new blood vessel growth, particularly under low oxygen conditions. When oxygen levels are low, Drp1 gets modified to produce reactive oxygen species (ROS), which enables glycolysis and subsequent cell signaling.
Researchers at the University of Houston have developed a novel technology to monitor membrane protein trafficking in real-time using bioluminescence. This allows for the study of cellular processes and drug development for heart disease, metabolic disorders, cancer, infectious diseases, COVID-19, and others.
Researchers found that mosquitoes' odor sensors shut down when forced to produce odor-related proteins, ignoring common insect repellents. This 'expression' process allows mosquitoes to adapt to their surroundings and avoids human scents.
Researchers have found that two receptors on the surface of endothelial cells come together to enable new blood vessel growth. The discovery reveals a new connection between copper metabolism and angiogenesis, highlighting CTR1 as a potential therapeutic target for conditions like ischemic heart disease.
The study reveals the Spike protein of SARS-CoV-2 directly binds exogeneous sialic acids, providing a new understanding of the virus's infection mechanism. This discovery opens up new therapeutic opportunities by targeting this interaction.
Researchers identified three KCTD proteins that modulate neurotransmitter activity, enabling fine-tuned movement. Their elimination enhances cAMP production and sensitivity to dopamine in neurons.
Researchers examined Kappa and Delta variant structures using cryo-EM, finding Delta's spike protein binds stronger with human ACE2 receptor. This explains the rapid global dominance of the Delta variant. The study provides insight into COVID-19 variants' evolution.
A new study reveals that SARS-CoV-2 limits viral particle release and instead spreads through cell-to-cell transmission, enabling efficient infection without the need for antibodies. This stealthy transmission method makes it challenging for the host immune system to target and neutralize the virus.
Researchers at PSI have developed a platform to measure biased signalling in G protein-coupled receptors (GPCRs), enabling selective therapeutic effects and fewer side effects. By testing specially designed bivalent ligands, they can bias signalling towards desired pathways.
A new study suggests that unborn babies could contract Covid-19 if their gut is exposed to the SARS-CoV-2 virus. However, researchers say that this risk is extremely limited due to the placenta's protective shield. Vaccination against Covid-19 during pregnancy is still recommended as a way to protect the unborn baby.
Scientists at UNC-Chapel Hill and UC San Francisco identified two receptors, MRGPRX2 and MRGPRX4, involved in itching. The researchers created high-resolution maps of these complex receptor proteins when bound to compounds causing itchiness, providing a template for designing new anti-itch medications.
A new study has identified the CCR2 gene as a key player in the progression of type 1 diabetes. The research found that lower blood levels of CCL-2, a ligand for CCR2, were associated with increased immune cell recruitment to the pancreas, leading to islet cell destruction.
A USF Health study reveals that fibrinogen can directly interact with neurons, leading to inflammation and neurodegeneration in Alzheimer's disease and traumatic brain injury. The researchers found that blocking the binding of fibrinogen to its receptors may alleviate short-term memory problems associated with these diseases.
A recent Johns Hopkins Medicine-led study suggests that statin use is not beneficial for reducing COVID-19 mortality or severity. Instead, patients taking statins had an increased risk of developing a more severe form of the disease. The researchers found no significant impact on mortality rates.
DZNE researchers found that viral molecules facilitate the intercellular spreading of protein aggregates, which are hallmarks of brain diseases like Alzheimer's. The presence of viral ligands increases protein aggregate spreading between cells, potentially contributing to neurodegeneration.
A team of international researchers has unraveled the inner workings of C5aR2, a key receptor involved in inflammation and COVID-19. The study provides an additional opportunity for therapeutic targeting with new drug molecules to block its activation and inflammation response.
Researchers developed a mathematical model to study the action of SARS-CoV-2, enabling the examination of individual virus particles and their spikes. This analysis can help fine-tune prevention and treatment by providing insights into viral load, spike distribution, and cell infection potential.
Researchers identify structure and interaction between HCV E2 protein and CD81 receptor, revealing acidic conditions enhance binding and facilitate cell entry. This discovery provides new leads for developing an HCV vaccine by targeting specific antibodies against the virus.